SG
Sugi Holdings Co.,Ltd.
SGIPF · OTC
$9.50 +0.00% (+$0.00)
1M +0.00%
Market Cap ¥275.7B
P/E Ratio 8.99x
Div. Yield 1.98%
ROE 10.75%
Bulios Fair Price
$14.21
49.7% upside
Current Price
$9.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SGIPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.27x
P/E 8.99x
P/B 0.94x
Growth
100 /100
Growing FCF growth 703.70%
EPS growth 586.31%
Book val. growth 468.08%
Profitability
25 /100
Weak Op. margin 4.86%
Gross margin 31.78%
FCF margin 0.00%
Quality
55 /100
Average ROA 4.80%
ROIC 8.28%
Asset turnover 1.62x
Debt
95 /100
Low Int. coverage 49.48x
Debt/Equity 0.32x
Net debt/EBITDA -0.48x
Stability
22 /100
Unstable EPS volatility 9,022.83%
Beta 0.31x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SGIPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Katsunori Sugiura
Employees
13,417
Headquarters
Obu
Upcoming events
08 OCT
Earnings
Upcoming earnings report
25 FEB
Ex-Dividend
Ex-dividend date
25 FEB
Dividend Payment
Payment date